United Therapeutics Corporation shares owned by Squarepoint Ops
Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Squarepoint Ops
from 13F filings
Historical chart of Squarepoint Ops investment in United Therapeutics Corporation
Tip: Access up to 7 years of quarterly data
All positions including United Therapeutics Corporation held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in United Therapeutics Corporation by Squarepoint Ops
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $14M | 33k | 419.21 |
| 2025-06-30 | $2.4M | 8.4k | 287.35 |
| 2025-03-31 | $4.2M | 14k | 308.27 |
| 2024-12-31 | $847k | 2.4k | 352.84 |
| 2024-09-30 | $3.5M | 9.9k | 358.35 |
| 2024-06-30 | $7.2M | 23k | 318.55 |
| 2024-03-31 | $42M | 183k | 229.72 |
| 2023-12-31 | $4.4M | 20k | 219.89 |
| 2023-09-30 | $9.1M | 40k | 225.87 |
| 2023-06-30 | $9.9M | 45k | 220.75 |
| 2023-03-31 | $985k | 4.4k | 223.96 |
| 2022-12-31 | $1.8M | 6.4k | 278.09 |
| 2022-09-30 | $272k | 1.3k | 209.23 |
| 2022-06-30 | $2.8M | 12k | 235.66 |
| 2022-03-31 | $3.4M | 19k | 179.42 |
| 2021-12-31 | $4.5M | 21k | 216.08 |
| 2021-09-30 | $7.0M | 38k | 184.59 |
| 2021-06-30 | $5.6M | 31k | 179.42 |
| 2021-03-31 | $4.6M | 27k | 167.27 |
| 2020-12-31 | $1.9M | 13k | 151.82 |
| 2020-09-30 | $1.8M | 18k | 100.99 |
| 2020-06-30 | $711k | 5.9k | 121.06 |
| 2020-03-31 | $4.8M | 50k | 94.82 |
| 2019-12-31 | $11M | 122k | 88.08 |
| 2019-09-30 | $9.5M | 119k | 79.75 |
| 2019-06-30 | $2.0M | 25k | 78.08 |
| 2019-03-31 | $4.3M | 36k | 117.37 |
| 2018-09-30 | $2.5M | 20k | 127.87 |
| 2018-03-31 | $353k | 3.1k | 112.31 |
| 2017-12-31 | $4.3M | 29k | 147.95 |
| 2017-09-30 | $1.2M | 11k | 117.19 |
| 2017-03-31 | $519k | 3.8k | 135.37 |
| 2016-09-30 | $1.4M | 12k | 118.08 |
| 2016-06-30 | $410k | 3.9k | 105.83 |
| 2016-03-31 | $2.2M | 20k | 111.42 |
| 2015-12-31 | $643k | 4.1k | 156.56 |
Top funds holding United Therapeutics Corporation
View all funds holding United Therapeutics Corporation